We are live on ! Find out more
SSP

Sixth Street Partners Portfolio holdings

AUM $711M
1-Year Est. Return 9.3%
This Fund
S&P 500
This Quarter Est. Return
-12.22%
1 Year Est. Return
-9.3%
3 Year Est. Return
+14.3%
5 Year Est. Return
+44.85%
10 Year Est. Return
AUM
$711M
AUM Growth
-$263M
Cap. Flow
-$96M
Cap. Flow %
-13.51%
Top 10 Hldgs %
100%
Holding
7
New
Increased
1
Reduced
2
Closed

Top Buys

Rank Stock Value
1
BATRK icon
Atlanta Braves Holdings Series B
BATRK
+$33.7M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$109M
2
PCG icon
PG&E
PCG
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.19%
2 Utilities 33.64%
3 Financials 10.31%
4 Communication Services 9.34%
5 Consumer Discretionary 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAI
1
Caris Life Sciences
CAI
$5.65B
$257M 36.19%
14,385,399
-5,000,000
-26% -$109M
PCG icon
2
PG&E
PCG
$37.4B
$239M 33.64%
13,609,288
-1,200,000
-8% -$20.4M
BATRK icon
3
Atlanta Braves Holdings Series B
BATRK
$3.13B
$66.3M 9.34%
1,553,822
+810,176
+109% +$33.7M
TSLX icon
4
Sixth Street Specialty
TSLX
$1.78B
$49.9M 7.02%
2,714,226
MBC icon
5
MasterBrand
MBC
$1.15B
$40.8M 5.74%
4,905,383
CXM icon
6
Sprinklr
CXM
$1.55B
$34M 4.79%
5,670,000
ESNT icon
7
Essent Group
ESNT
$6.04B
$23.4M 3.29%
400,000

Similar funds

Sixth Street Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Sixth Street Partners held 7 positions worth $711M, down 27% from $974M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sixth Street Partners withdrew a net $96M in Q1 2026, reducing 2 holdings. Its largest reduction was Caris Life Sciences, cutting an estimated $109M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 54% a quarter earlier, followed by Utilities and Financials.

Against the trend, Sixth Street Partners added an estimated $33.7M to Atlanta Braves Holdings Series B.

  • Sixth Street Partners added most to Atlanta Braves Holdings Series B in Q1 2026, an estimated $33.7M increase.
  • Sixth Street Partners's biggest Q1 2026 reduction was Caris Life Sciences, cutting an estimated $109M.
  • Sixth Street Partners's ten largest holdings make up 100% of its $711M portfolio in Q1 2026.
  • Sixth Street Partners opened 0 new positions and closed 0 in Q1 2026.
  • Sixth Street Partners's portfolio value fell 27% quarter-over-quarter to $711M.

Based on Sixth Street Partners's 13F filing for Q1 2026, filed 15 May 2026.